About Us
Our Therapy Areas
Products
Gastroenterology
Cardiology and Vascular disease
Neurology and Psychiatry
Respiratory and Allergy
Antimicrobials
Pain and Inflammation
Hematology therapy area
Endocrinology
Urinary Tract and Lithiasis
View All
Trixacar
Partners
Media
Press Release
Articles
Contact us
Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19
Associations between gut microbiota composition, levels of cytokines and inflammatory markers in patients with COVID-19 suggest that the gut microbiome is involved in the magnitude of COVID-19 severity possibly via modulating host immune responses.
Furthermore, the gut microbiota dysbiosis after disease resolution could contribute to persistent symptoms, highlighting a need to understand how gut microorganisms are involved in inflammation and COVID-19.
Back to Articles
Search Products